Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20250317910784/en/TNF-Pharmaceuticals-Delivers-Podium-Presentation-of-Novel-Oral-TNF-Alpha-Inhibitor-at-Premier-International-Conference-on-Frailty-and-Sarcopenia
Mar 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next